Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Feb 4, 2021
For-profit organization
Multi-language Support for the Winterlight Assessment App
969026
Winterlight Labs (WLL) developed software for detecting and monitoring symptoms of language impairment
associated with aphasia, dementia, and other cognitive and mental health conditions using speech analysis
algorithms, based on multi-year academic research. The current status of research and technology is limited by
using the corpora of English speech only. As such, the goal of the project is to extend the capabilities of WLL
developed software by adding multi-language support to various stages of the existing process. Given the number of
clinical trial sites in different countries across the world, the following languages were identified as top-priorities from
the business perspective: 1) Spanish, 2) French, 3) German.